PI3K δ is a Treg target in cancer immunotherapy.
This article is protected by copyright. All rights reserved.
PMID: 31107985 [PubMed - as supplied by publisher]
Source: Immunology - Category: Allergy & Immunology Authors: Lim EL, Okkenhaug K Tags: Immunology Source Type: research